AstraZeneca Pharma India Limited (NSE:ASTRAZEN)
India
· Delayed Price · Currency is INR 8,465.50
-107.50 (-1.25%)
Apr 28, 2026, 3:29 PM IST
AstraZeneca Pharma India Employees
AstraZeneca Pharma India had 802 employees as of March 31, 2025. The number of employees decreased by 138 or -14.68% compared to the previous year.
Employees
802
Change (1Y)
-138
Growth (1Y)
-14.68%
Revenue / Employee
36.29M INR
Profits / Employee
3.35M INR
Market Cap
211.45B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Piramal Pharma | 5,476 |
| Wockhardt | 2,296 |
| NATCO Pharma | 4,199 |
| Eris Lifesciences | 3,354 |
| Cohance Lifesciences | 1,212 |
| Gland Pharma | 4,351 |
| Emcure Pharmaceuticals | 6,731 |
| Alembic Pharmaceuticals | 16,571 |
AstraZeneca Pharma India News
- 18 days ago - AstraZeneca Pharma India secures approval to market Calquence for new indication - Business Upturn
- 21 days ago - AstraZeneca, Telangana govt to roll out AI-powered lung cancer screening in public hospitals - The Times of India
- 4 weeks ago - AstraZeneca Pharma India appoints Dr. Shashank Srinivasan and promotes Mr. Venkat Natarajan - Business Upturn
- 5 weeks ago - AstraZeneca Pharma India announces resignation of non-executive director Jesús Diaz-Ropero Esteso - Business Upturn
- 6 weeks ago - AstraZeneca Pharma India receives approval to market Imfinzi for unresectable hepatocellular carcinoma - Business Upturn
- 2 months ago - ASTRAZEN shares fall over 4% as Q3 EBITDA drops 41.8% YoY to Rs 44.8 crore - Business Upturn
- 2 months ago - Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In First-Line Treatment - NDTV
- 4 months ago - AstraZeneca Pharma India receives CDSCO approval to import and market Datverzo in India - Business Upturn